HOME › Research Insight › Key players in the Newborn Screening Market Are Focusing on New Product Launches, Acquisitions, Agreements, Collaborations, Contracts, Partnerships, and Expansions to Hold Their Market Positions
Key players in the Newborn Screening Market Are Focusing on New Product Launches, Acquisitions, Agreements, Collaborations, Contracts, Partnerships, and Expansions to Hold Their Market Positions
The prominent players in the newborn screening market are AB SCIEX LLC (U.S.), Agilent Technologies (U.S.), Bio-Rad Laboratories (U.S.), Covidien PLC (Ireland), GE Life Sciences (U.K.), Masimo Corporation (U.S.), Natus Medical Inc. (U.S.), PerkinElmer Inc. (U.S.), Trivitron Healthcare (India), and Waters Corporation (U.S.).
PerkinElmer (U.S.) was the global leader in the newborn screening market in 2013; approximately 415 million infants had been screened by the company’s products. It is a well-known company and has an exhaustive product portfolio. The company believes that a strong intellectual property portfolio plays an important role in enhancing its market share. The company is innovation-centric and invests heavily in R&D for maintaining its market share. Moreover, the company adapts geographic expansions as its major strategy for enhancing its market share in the geographies which have greatest sales potential according to the company. In this regard, in June 2014, PerkinElmer collaborated with China's National Health and Family Planning Commission (NHFPC) for implementing a three-year newborn screening training program in rural China.
The key strategies followed by most companies in the newborn screening market are new product launches, agreements, collaborations, partnerships, contracts, acquisitions, approvals, and expansions. Among all growth strategies being adopted by the market players in this field, agreements, collaborations, partnerships, and contracts accounted for the largest share of the overall growth strategies mapped from 2011 to 2014 to leverage the newborn screening market growth opportunities. Some leading players adopting this strategy include AB SCIEX (U.S.), Agilent Technologies (U.S.), Covidien PLC (Ireland), GE Life Sciences (U.K.), Masimo Corporation (U.S.), PerkinElmer Inc. (U.S.), and Trivitron Healthcare (India). New product launches accounted for the second-largest share of overall growth strategies adopted by players in the market
NewBorn Screening Market by Test Type (Dried Blood Spot, Hearing Screening, CCHD), Technology (Tandem Mass Spectrometry, Immunoassay, Enzyme Assay, Electrophoresis, Pulse Oximeter), Instrument, Accessories, Reagent & Assay Kit – Global Forecast to 2019
North - Dominion Plaza,
17304 Preston Road,
Suite 800, Dallas, TX 75252